REQUEST A DEMO
Total
USD $0.00
Search more companies

Psicofarma del Ecuador S.A. (PSICODELCU) (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Psicofarma del Ecuador S.A. (PSICODELCU) Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Psicofarma, S.A. De C.V., S.A. De C.V. is a Mexican company specializing in the development and manufacturing of safe and effective quality medicines for mental health and chronic degenerative diseases, with a focus on diseases of the Central Nervous System. They offer a comprehensive line of specialized medications for conditions such as Depression, Anxiety, Schizophrenia, Bipolar Disorder, ADHD, Parkinson, Epilepsy, Migraine, Neuropathic pain, Oncological pain, and addictions. Psicofarma, S.A. De C.V. has 34 products and 90 presentations, and their processes strictly adhere to national and international health regulations.

Headquarters
Nahim Isaias Km. Na, Colon Square Bldg. , Floor 54
Guayaquil; Guayas;

Contact Details: Purchase the Psicofarma del Ecuador S.A. (PSICODELCU) report to view the information.

Website: https://psicofarma.com.mx/

Basic Information
Total Employees:
Purchase the Psicofarma del Ecuador S.A. (PSICODELCU) report to view the information.
Outstanding Shares:
Purchase the Psicofarma del Ecuador S.A. (PSICODELCU) report to view the information.
Registered Capital:
Purchase the Psicofarma del Ecuador S.A. (PSICODELCU) report to view the information.
Incorporation Date:
August 05, 2003
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.96%
Purchase this report to view the information.
0.04%
Company Performance
Financial values in the chart are available after Psicofarma del Ecuador S.A. (PSICODELCU) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-38.45%
Total operating revenue
-38.45%
Operating profit (EBIT)
-84.49%
EBITDA
-84.44%
Net Profit (Loss) for the Period
24.99%
Total assets
-23.3%
Total equity
8.13%
Operating Profit Margin (ROS)
-48.24%
Net Profit Margin
0.61%
Return on Equity (ROE)
1.02%
Quick Ratio
-4.39%
Cash Ratio
1.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?